English 
Français Our Market Access Expertise
Development and implementation of analysis and tools to support Market Access strategy for new healthcare products
Analysis of international healthcare policies and pricing & reimbursement procedures to support negotiations with government authorities:
- Mapping of healthcare systems
- Analysis of decision makers’ decision criteria
- Burden of disease evaluation: severity of the disease (incidence, prevalence), comorbidities
- Target population evaluation
- Disease unmet needs evaluation in current indication
- Disease cost effectiveness and budget impact evaluation
Identification of private (non-reimbursed) and public (reimbursed) market opportunities
Operational support during evaluation procedures in France:
- Preparation and submission of reimbursement files in France with healthcare authorities (ANSM, HAS, CT, CEEPS and CEPS): development of clinical and economical arguments
